Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan

28. februar 2014 oppdatert av: Boehringer Ingelheim

Additional Effect of a Life Style Program on Antihypertensive Treatment With Telmisartan

This post-marketing surveillance study is designed to supplement the data on efficacy and tolerability of Micardis® and MicardisPlus® in patients at cardiovascular risk under general practice conditions.

The aim of the study is to investigate the effect of a six-month treatment with Micardis® / MicardisPlus® on blood pressure and the effect of the Lifestyle education tool for weight reduction on blood pressure control.

In addition, the post-marketing surveillance study will provide information on the effects on target measurement of the Lifestyle education tool and various laboratory parameters produced by treatment with Micardis® and MicardisPlus® in an unselected patient population under general practice conditions.

Studieoversikt

Status

Fullført

Forhold

Hypertensjon

Studietype

Observasjonsmessig

Registrering (Faktiske)

1856

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Slovenia
- - ?adca, Slovenia
    - Boehringer Ingelheim Investigational Site 34
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 2
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 3
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 4
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 5
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 6
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 7
  - Banská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 8
  - Bardejov, Slovenia
    - Boehringer Ingelheim Investigational Site 10
  - Bardejov, Slovenia
    - Boehringer Ingelheim Investigational Site 11
  - Bardejov, Slovenia
    - Boehringer Ingelheim Investigational Site 12
  - Bardejov, Slovenia
    - Boehringer Ingelheim Investigational Site 9
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 13
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 14
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 15
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 16
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 17
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 18
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 19
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 20
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 21
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 22
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 23
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 24
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 25
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 26
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 27
  - Bratislava, Slovenia
    - Boehringer Ingelheim Investigational Site 28
  - Brezno, Slovenia
    - Boehringer Ingelheim Investigational Site 29
  - Brezno, Slovenia
    - Boehringer Ingelheim Investigational Site 30
  - Brezno, Slovenia
    - Boehringer Ingelheim Investigational Site 31
  - Brezno, Slovenia
    - Boehringer Ingelheim Investigational Site 32
  - Byt?a, Slovenia
    - Boehringer Ingelheim Investigational Site 33
  - Bánovce nad Bebravou, Slovenia
    - Boehringer Ingelheim Investigational Site 1
  - Dolný Kubín, Slovenia
    - Boehringer Ingelheim Investigational Site 35
  - Dubnica nad Váhom, Slovenia
    - Boehringer Ingelheim Investigational Site 36
  - Dubnica nad Váhom, Slovenia
    - Boehringer Ingelheim Investigational Site 37
  - Dunajská Streda, Slovenia
    - Boehringer Ingelheim Investigational Site 38
  - Dunajská Streda, Slovenia
    - Boehringer Ingelheim Investigational Site 39
  - Dunajská Streda, Slovenia
    - Boehringer Ingelheim Investigational Site 40
  - Dunajská Streda, Slovenia
    - Boehringer Ingelheim Investigational Site 41
  - Dunajská Streda, Slovenia
    - Boehringer Ingelheim Investigational Site 42
  - Dunajská Streda, Slovenia
    - Boehringer Ingelheim Investigational Site 43
  - Galanta, Slovenia
    - Boehringer Ingelheim Investigational Site 44
  - Galanta, Slovenia
    - Boehringer Ingelheim Investigational Site 45
  - Handlová, Slovenia
    - Boehringer Ingelheim Investigational Site 46
  - Hlohovec, Slovenia
    - Boehringer Ingelheim Investigational Site 47
  - Hlohovec, Slovenia
    - Boehringer Ingelheim Investigational Site 48
  - Hnús?a, Slovenia
    - Boehringer Ingelheim Investigational Site 49
  - Hurbanovo, Slovenia
    - Boehringer Ingelheim Investigational Site 50
  - Jesenské, Slovenia
    - Boehringer Ingelheim Investigational Site 51
  - Kezmarok, Slovenia
    - Boehringer Ingelheim Investigational Site 52
  - Kolárovo, Slovenia
    - Boehringer Ingelheim Investigational Site 53
  - Komárno, Slovenia
    - Boehringer Ingelheim Investigational Site 54
  - Komárno, Slovenia
    - Boehringer Ingelheim Investigational Site 55
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 56
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 57
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 58
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 59
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 60
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 61
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 62
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 63
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 64
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 65
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 66
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 67
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 68
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 69
  - Kosice, Slovenia
    - Boehringer Ingelheim Investigational Site 70
  - Krá?ovský Chlmec, Slovenia
    - Boehringer Ingelheim Investigational Site 71
  - Kysucké Nové Mesto, Slovenia
    - Boehringer Ingelheim Investigational Site 72
  - Kysucké Nové Mesto, Slovenia
    - Boehringer Ingelheim Investigational Site 73
  - Kysucké Nové Mesto, Slovenia
    - Boehringer Ingelheim Investigational Site 74
  - Levice, Slovenia
    - Boehringer Ingelheim Investigational Site 75
  - Levice, Slovenia
    - Boehringer Ingelheim Investigational Site 76
  - Levice, Slovenia
    - Boehringer Ingelheim Investigational Site 77
  - Lipany, Slovenia
    - Boehringer Ingelheim Investigational Site 78
  - Lu?enec, Slovenia
    - Boehringer Ingelheim Investigational Site 79
  - Lu?enec, Slovenia
    - Boehringer Ingelheim Investigational Site 80
  - Lu?enec, Slovenia
    - Boehringer Ingelheim Investigational Site 81
  - Lu?enec, Slovenia
    - Boehringer Ingelheim Investigational Site 82
  - Martin, Slovenia
    - Boehringer Ingelheim Investigational Site 83
  - Martin, Slovenia
    - Boehringer Ingelheim Investigational Site 84
  - Martin, Slovenia
    - Boehringer Ingelheim Investigational Site 85
  - Michalovce, Slovenia
    - Boehringer Ingelheim Investigational Site 86
  - Michalovce, Slovenia
    - Boehringer Ingelheim Investigational Site 87
  - Michalovce, Slovenia
    - Boehringer Ingelheim Investigational Site 88
  - Myjava, Slovenia
    - Boehringer Ingelheim Investigational Site 89
  - Nitra, Slovenia
    - Boehringer Ingelheim Investigational Site 91
  - Nitra, Slovenia
    - Boehringer Ingelheim Investigational Site 92
  - Nitra, Slovenia
    - Boehringer Ingelheim Investigational Site 93
  - Nitra, Slovenia
    - Boehringer Ingelheim Investigational Site 94
  - Nové Mesto nad Váhom, Slovenia
    - Boehringer Ingelheim Investigational Site 95
  - Nové Mesto nad Váhom, Slovenia
    - Boehringer Ingelheim Investigational Site 96
  - Nové Mesto nad Váhom, Slovenia
    - Boehringer Ingelheim Investigational Site 97
  - Nové Zámky, Slovenia
    - Boehringer Ingelheim Investigational Site 100
  - Nové Zámky, Slovenia
    - Boehringer Ingelheim Investigational Site 101
  - Nové Zámky, Slovenia
    - Boehringer Ingelheim Investigational Site 98
  - Nové Zámky, Slovenia
    - Boehringer Ingelheim Investigational Site 99
  - Námestovo, Slovenia
    - Boehringer Ingelheim Investigational Site 90
  - Partizánske, Slovenia
    - Boehringer Ingelheim Investigational Site 102
  - Partizánske, Slovenia
    - Boehringer Ingelheim Investigational Site 103
  - Pezinok, Slovenia
    - Boehringer Ingelheim Investigational Site 104
  - Pies?any, Slovenia
    - Boehringer Ingelheim Investigational Site 105
  - Poprad, Slovenia
    - Boehringer Ingelheim Investigational Site 106
  - Poprad, Slovenia
    - Boehringer Ingelheim Investigational Site 107
  - Poprad, Slovenia
    - Boehringer Ingelheim Investigational Site 108
  - Povazská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 109
  - Povazská Bystrica, Slovenia
    - Boehringer Ingelheim Investigational Site 110
  - Presov, Slovenia
    - Boehringer Ingelheim Investigational Site 111
  - Presov, Slovenia
    - Boehringer Ingelheim Investigational Site 112
  - Presov, Slovenia
    - Boehringer Ingelheim Investigational Site 113
  - Presov, Slovenia
    - Boehringer Ingelheim Investigational Site 114
  - Prievidza, Slovenia
    - Boehringer Ingelheim Investigational Site 115
  - Prievidza, Slovenia
    - Boehringer Ingelheim Investigational Site 116
  - Prievidza, Slovenia
    - Boehringer Ingelheim Investigational Site 117
  - Rajec, Slovenia
    - Boehringer Ingelheim Investigational Site 118
  - Revúca, Slovenia
    - Boehringer Ingelheim Investigational Site 119
  - Revúca, Slovenia
    - Boehringer Ingelheim Investigational Site 120
  - Rimavská Sobota, Slovenia
    - Boehringer Ingelheim Investigational Site 121
  - Rimavská Sobota, Slovenia
    - Boehringer Ingelheim Investigational Site 122
  - Rimavská Sobota, Slovenia
    - Boehringer Ingelheim Investigational Site 123
  - Roz?ava, Slovenia
    - Boehringer Ingelheim Investigational Site 124
  - Roz?ava, Slovenia
    - Boehringer Ingelheim Investigational Site 125
  - Ruzomberok, Slovenia
    - Boehringer Ingelheim Investigational Site 126
  - Ruzomberok, Slovenia
    - Boehringer Ingelheim Investigational Site 127
  - Sa?a, Slovenia
    - Boehringer Ingelheim Investigational Site 128
  - Sa?a, Slovenia
    - Boehringer Ingelheim Investigational Site 129
  - Sa?a, Slovenia
    - Boehringer Ingelheim Investigational Site 130
  - Se?ovce, Slovenia
    - Boehringer Ingelheim Investigational Site 131
  - Se?ovce, Slovenia
    - Boehringer Ingelheim Investigational Site 132
  - Skalica, Slovenia
    - Boehringer Ingelheim Investigational Site 133
  - Snina, Slovenia
    - Boehringer Ingelheim Investigational Site 134
  - Snina, Slovenia
    - Boehringer Ingelheim Investigational Site 135
  - Spisská Nová Ves, Slovenia
    - Boehringer Ingelheim Investigational Site 136
  - Spisská Nová Ves, Slovenia
    - Boehringer Ingelheim Investigational Site 137
  - Stará ?ubov?a, Slovenia
    - Boehringer Ingelheim Investigational Site 138
  - Stará ?ubov?a, Slovenia
    - Boehringer Ingelheim Investigational Site 139
  - Stará ?ubov?a, Slovenia
    - Boehringer Ingelheim Investigational Site 140
  - Stropkov, Slovenia
    - Boehringer Ingelheim Investigational Site 141
  - Stúrovo, Slovenia
    - Boehringer Ingelheim Investigational Site 142
  - Surany, Slovenia
    - Boehringer Ingelheim Investigational Site 143
  - Surany, Slovenia
    - Boehringer Ingelheim Investigational Site 144
  - Svit, Slovenia
    - Boehringer Ingelheim Investigational Site 145
  - Topo??any, Slovenia
    - Boehringer Ingelheim Investigational Site 146
  - Torna?a, Slovenia
    - Boehringer Ingelheim Investigational Site 147
  - Trebisov, Slovenia
    - Boehringer Ingelheim Investigational Site 148
  - Trebisov, Slovenia
    - Boehringer Ingelheim Investigational Site 149
  - Trebisov, Slovenia
    - Boehringer Ingelheim Investigational Site 150
  - Tren?ín, Slovenia
    - Boehringer Ingelheim Investigational Site 151
  - Tren?ín, Slovenia
    - Boehringer Ingelheim Investigational Site 152
  - Tren?ín, Slovenia
    - Boehringer Ingelheim Investigational Site 153
  - Tren?ín, Slovenia
    - Boehringer Ingelheim Investigational Site 154
  - Trnava, Slovenia
    - Boehringer Ingelheim Investigational Site 155
  - Trnava, Slovenia
    - Boehringer Ingelheim Investigational Site 156
  - Trnava, Slovenia
    - Boehringer Ingelheim Investigational Site 157
  - Trnava, Slovenia
    - Boehringer Ingelheim Investigational Site 158
  - Trstená, Slovenia
    - Boehringer Ingelheim Investigational Site 159
  - Tur?ianske Teplice, Slovenia
    - Boehringer Ingelheim Investigational Site 160
  - Turzovka, Slovenia
    - Boehringer Ingelheim Investigational Site 161
  - Ve?ké Kapusany, Slovenia
    - Boehringer Ingelheim Investigational Site 162
  - Ve?ké Kapusany, Slovenia
    - Boehringer Ingelheim Investigational Site 163
  - Ve?ký Krtís, Slovenia
    - Boehringer Ingelheim Investigational Site 164
  - Ve?ký Krtís, Slovenia
    - Boehringer Ingelheim Investigational Site 165
  - Vranov nad Top?ou, Slovenia
    - Boehringer Ingelheim Investigational Site 167
  - Vráble, Slovenia
    - Boehringer Ingelheim Investigational Site 166
  - Zarnovica, Slovenia
    - Boehringer Ingelheim Investigational Site 168
  - Zeliezovce, Slovenia
    - Boehringer Ingelheim Investigational Site 169
  - Zilina, Slovenia
    - Boehringer Ingelheim Investigational Site 170
  - Zilina, Slovenia
    - Boehringer Ingelheim Investigational Site 171
  - Zilina, Slovenia
    - Boehringer Ingelheim Investigational Site 172
  - Zilina, Slovenia
    - Boehringer Ingelheim Investigational Site 173
  - Zilina, Slovenia
    - Boehringer Ingelheim Investigational Site 174
  - Zilina, Slovenia
    - Boehringer Ingelheim Investigational Site 175
  - Zlaté Moravce, Slovenia
    - Boehringer Ingelheim Investigational Site 176
  - Zlaté Moravce, Slovenia
    - Boehringer Ingelheim Investigational Site 177
  - Zlaté Moravce, Slovenia
    - Boehringer Ingelheim Investigational Site 178
  - Zvolen, Slovenia
    - Boehringer Ingelheim Investigational Site 179
  - Zvolen, Slovenia
    - Boehringer Ingelheim Investigational Site 180
  - Zvolen, Slovenia
    - Boehringer Ingelheim Investigational Site 181
  - Zvolen, Slovenia
    - Boehringer Ingelheim Investigational Site 182

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

Patients with hypertension

Beskrivelse

Inclusion criteria:

Patients with essential hypertension (blood pressure (BP) higher or equal to 140/90 mmHg or higher or equal to 130/80 mmHg in case of diabetic patients)
Patients with hypertension under treatment with one or more antihypertensive drug

Exclusion criteria:

Patients are excluded according to the summary of product characteristics (SmPC).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Antall grupper / kohorter

Kohorter og intervensjoner

Gruppe / Kohort
Patients at cardiovascular risk

Hva måler studien?

Primære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Changes in Mean Blood Pressure (Systolic) After Treatment, Compared to Baseline Tidsramme: 24 weeks (Visit 1 to Visit 3)	Changes in blood pressure in patients with systolic values, measured at baseline and final visit, by treatment and by Tool/No Tool	24 weeks (Visit 1 to Visit 3)
Changes in Mean Blood Pressure (Diastolic) After Treatment, Compared to Baseline Tidsramme: 24 weeks (Visit 1 to Visit 3)	Changes in blood pressure in patients with diastolic values, measured at baseline and final visit, by treatment and by Tool/No Tool	24 weeks (Visit 1 to Visit 3)

Sekundære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Changes in Laboratory Parameters:Low Density Lipoprotein (LDL) Tidsramme: 24 weeks (Visit 1 to Visit 3)	Changes in LDL cholesterol levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool	24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters:High Density Lipoprotein (HDL) Tidsramme: 24 weeks (Visit 1 to Visit 3)	Changes in LDL cholesterol levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool	24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters: Triglycerides Tidsramme: 24 weeks (Visit 1 to Visit 3)	Changes in the triglyceride levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool	24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters: Blood Glucose Tidsramme: 24 weeks (Visit 1 to Visit 3)	Changes in the fasting blood glucose levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool	24 weeks (Visit 1 to Visit 3)
Assessment of Metabolic Effect Tidsramme: 24 weeks (Visit 1 to Visit 3)	Metabolic effect was rated by the investigators as 'positive', 'neutral' and 'negative'	24 weeks (Visit 1 to Visit 3)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Boehringer Ingelheim

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Hjelpsomme linker

Related Info

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. september 2008

Primær fullføring (Faktiske)

1. september 2009

Studiet fullført (Faktiske)

1. september 2009

Datoer for studieregistrering

Først innsendt

11. mars 2010

Først innsendt som oppfylte QC-kriteriene

21. april 2010

Først lagt ut (Anslag)

22. april 2010

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

10. april 2014

Siste oppdatering sendt inn som oppfylte QC-kriteriene

28. februar 2014

Sist bekreftet

1. februar 2014

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

502.579

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Hypertensjon

University Hospital of Cologne

Ukjent

24-timers ambulatorisk blodtrykksovervåking og pulsbølgeanalyse hos NAFLD-pasienter (HyperNAFLD)

NAFLD; Hypertensjon, White-Coat Hypertension, Masked Hypertension

Tyskland
Karolinska Institutet

Fullført

White-coat hypertensjon i barndommen - Effekter på blodtrykk og organskader (WCH)

White Coat Hypertension
Clinical Hospital Centre Zagreb
European Society of Hypertension

Ukjent

Blodtrykkskontroll i ESH Excellence Centers (BP-CON)

White Coat Hypertension | Blodtrykk | Livsstilsrisikoreduksjon

Israel, Hellas, Belgia, Tyskland, Armenia, Østerrike, Bulgaria, Kroatia, Tsjekkia, Estland, Italia, Libanon, Litauen, Nederland, Polen, Portugal, Romania, Serbia, Spania, Sverige, Ukraina, Storbritannia
Regional Hospital Holstebro

Fullført

Hjertefrekvensvariasjon i White Coat Hypertension og Essential Hypertension

Sunn | White Coat Hypertension | Essensiell hypertensjon

Danmark
Columbia University
Agency for Healthcare Research and Quality (AHRQ)

Aktiv, ikke rekrutterende

Implementing Hypertension Screening Guidelines in Primary Care

White Coat Hypertension | Hypertensjon, viktig

Forente stater
University of Alabama at Birmingham
Troy University

Fullført

Bruk av automatisert kontorblodtrykksmåling

Hypertensjon | Hypertensjon, motstandsdyktig mot konvensjonell terapi | Ukontrollert hypertensjon | Hypertensjon, hvit pels

Forente stater
PD Dr. Grégoire Wuerzner
Swiss National Science Foundation

Fullført

Nyrerespons på underkroppens negativt trykk i pre-hypertensive tilstander

Hypertensjon | Overvekt | White Coat Hypertension | Resistent hypertensjon

Sveits
University Hospital, Tours

Fullført

PTFE-dekkede stenter versus nakne stenter i TIPS (Transjugulær Intra-hepatisk Porto-systemisk shunt)

Cirrhotic Portal Hypertension

Frankrike
Sun Yat-sen University

Fullført

Optimal behandling av hepatocellulært karsinom (HCC) med cirrhotisk portalhypertensjon

Hepatocellulært karsinom (HCC) | Cirrhotic Portal Hypertension

Kina

Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan